Main > ENDOCRINOLOGY > Diabetes. Treatment > Glycogen Phosphorylase Inhibitors > Patent > Claims > Claim 1: Compd of Formula STR28 > Claim 5: 5-Acetyl-1-Et-2-Oxo-2,3-Di > -H-1H-Indole-3-Carboxylic Acid (3-p > -TolylCarbamoyl-Ph)-Amide Etc. > Claim 11: Diabetes Treat. Claim 22: > Diabetes Combi. Treat.: a) > Glycogen Phosphorylase Inhibitor > & b) AntiDiabetic Select: Insulin > Etc. Patent Assignee
Etc. Patent Assignee's products
USA. P